TScan Therapeutics (TCRX) Short Interest Ratio & Short Volume $1.44 +0.14 (+10.77%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.42 -0.01 (-1.04%) As of 04/17/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TScan Therapeutics Short Interest DataTScan Therapeutics (TCRX) has a short interest of 2.03 million shares, representing 4.69% of the float (the number of shares available for trading by the public). This marks a 6.84% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.9, indicating that it would take 4.9 days of the average trading volume of 349,691 shares to cover all short positions.Current Short Interest2,030,000 sharesPrevious Short Interest1,900,000 sharesChange Vs. Previous Month+6.84%Dollar Volume Sold Short$2.80 millionShort Interest Ratio4.9 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares56,591,000 sharesFloat Size43,270,000 sharesShort Percent of Float4.69%Today's Trading Volume1,012,762 sharesAverage Trading Volume349,691 sharesToday's Volume Vs. Average290% Short Selling TScan Therapeutics? Sign up to receive the latest short interest report for TScan Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTCRX Short Interest Over TimeTCRX Days to Cover Over TimeTCRX Percentage of Float Shorted Over Time TScan Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20252,030,000 shares $2.80 million +6.8%4.7%4.9 $1.38 3/15/20251,900,000 shares $3.31 million -14.8%4.4%4.4 $1.74 2/28/20252,230,000 shares $4.68 million +11.5%5.2%4.8 $2.10 2/15/20252,000,000 shares $4.10 million +9.9%4.9%4.5 $2.05 1/31/20251,820,000 shares $4.68 million -9.0%4.2%4.5 $2.57 1/15/20252,000,000 shares $5.30 million -20.6%4.6%5 $2.65 12/31/20242,520,000 shares $7.66 million +7.2%5.8%6.4 $3.04 12/15/20242,350,000 shares $6.70 million +1.3%5.4%7.5 $2.85 11/30/20242,320,000 shares $11.07 million +0.9%5.3%9.4 $4.77 11/15/20242,300,000 shares $10.14 million +6.5%5.3%10.5 $4.41 Get the Latest News and Ratings for TCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/20242,160,000 shares $9.81 million -3.6%5.2%9.6 $4.54 10/15/20242,240,000 shares $12.39 million +8.2%5.4%10.7 $5.53 9/30/20242,070,000 shares $10.31 million +15.0%5.0%9.3 $4.98 9/15/20241,800,000 shares $10.33 million +31.4%4.3%5 $5.74 8/31/20241,370,000 shares $7.71 million +9.6%3.3%3.8 $5.63 8/15/20241,250,000 shares $7.24 million +5.9%3.0%3.5 $5.79 7/31/20241,180,000 shares $8.43 million +15.7%2.9%3.3 $7.14 7/15/20241,020,000 shares $7.24 million +67.7%2.5%3 $7.10 6/30/2024608,200 shares $3.56 million +18.7%1.5%1.7 $5.85 6/15/2024512,400 shares $4.30 million +6.1%1.2%2.2 $8.40 5/31/2024482,800 shares $4.13 million +26.5%1.2%2.3 $8.55 5/15/2024381,800 shares $3.41 million -4.1%0.9%1.9 $8.93 4/30/2024398,000 shares $3.07 million -5.2%1.0%1.9 $7.72 4/15/2024419,700 shares $3.23 million +91.3%1.1%2.2 $7.69 3/31/2024219,400 shares $1.74 million +16.5%0.6%1.3 $7.94 3/15/2024188,300 shares $1.34 million +0.3%0.5%1.2 $7.12 2/29/2024187,700 shares $1.27 million -25.8%0.5%1.2 $6.75 2/15/2024252,900 shares $1.45 million +3.8%0.7%1.6 $5.74 1/31/2024243,600 shares $1.24 million -6.4%0.6%1.8 $5.11 1/15/2024260,300 shares $1.56 million -14.6%0.7%2 $6.00 12/31/2023304,700 shares $1.78 million -14.1%0.8%2.3 $5.83 12/15/2023354,700 shares $1.76 million -5.0%0.9%3.1 $4.95 11/30/2023373,300 shares $2.44 million -10.3%1.0%3.1 $6.53 11/15/2023416,000 shares $1.98 million -11.6%1.1%3.5 $4.76 10/31/2023470,700 shares $1.81 million -10.5%1.2%4.4 $3.85 10/15/2023526,000 shares $1.77 million -7.2%1.4%5.1 $3.37 9/30/2023566,900 shares $1.45 million +50.5%1.5%4.7 $2.56 9/15/2023376,800 shares $1.09 million +12.5%1.0%2.9 $2.89 8/31/2023334,800 shares $796,824.00 -5.0%0.9%2.5 $2.38 8/15/2023352,300 shares $739,830.00 -9.8%0.9%1.4 $2.10The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a 7/31/2023390,700 shares $875,168.00 +9.0%0.9%0.3 $2.24 7/15/2023358,400 shares $756,224.00 -5.6%0.8%0.2 $2.11 6/30/2023379,600 shares $949,000.00 -5.6%0.9%0.3 $2.50 6/15/2023401,900 shares $1.09 million -19.6%1.0%0.3 $2.72 5/31/2023499,900 shares $1.15 million +19.8%1.4%0.4 $2.30 5/15/2023417,400 shares $1.68 million +365.9%2.9%0.3 $4.03 4/30/202389,600 shares $203,392.00 -2.3%0.7%0.1 $2.27 4/15/202391,700 shares $200,823.00 -24.7%0.7%0.6 $2.19 3/31/2023121,700 shares $255,570.00 -21.0%0.9%0.8 $2.10 3/15/2023154,000 shares $403,480.00 -2.0%1.2%1 $2.62 2/28/2023157,100 shares $463,445.00 +4.0%1.2%1 $2.95 2/15/2023151,000 shares $407,700.00 -50.3%1.2%1 $2.70 1/31/2023303,800 shares $552,916.00 +109.7%3.3%2.2 $1.82 1/15/2023144,900 shares $318,780.00 -1.6%1.6%1.1 $2.20 12/30/2022147,200 shares $228,160.00 +1.1%1.6%5.8 $1.55 12/15/2022145,600 shares $276,640.00 -5.9%1.6%7.4 $1.90 11/30/2022154,800 shares $334,368.00 -3.9%1.7%8.5 $2.16 11/15/2022161,000 shares $431,480.00 +14.9%1.8%8.5 $2.68 10/31/2022140,100 shares $378,270.00 +151.5%1.5%7.3 $2.70 10/15/202255,700 shares $167,100.00 -7.0%0.6%2.6 $3.00 9/30/202259,900 shares $182,695.00 +12.6%0.7%3 $3.05 9/15/202253,200 shares $173,432.00 +731.3%0.6%2.5 $3.26 8/31/20226,400 shares $17,600.00 -96.8%0.1%0.3 $2.75 8/15/2022202,300 shares $681,751.00 +12.3%2.2%9.9 $3.37 7/31/2022180,200 shares $791,078.00 +8.8%2.0%1.9 $4.39 7/15/2022165,700 shares $565,037.00 +5.5%1.8%1.7 $3.41 6/30/2022157,000 shares $493,765.00 -0.2%1.7%1.5 $3.15 6/15/2022157,300 shares $493,922.00 +17.0%1.7%1.3 $3.14 5/31/2022134,500 shares $430,400.00 -41.9%1.5%1.1 $3.20 5/15/2022231,600 shares $576,684.00 +830.1%2.5%1.9 $2.49 4/30/202224,900 shares $53,535.00 +11.2%0.3%0.4 $2.15 4/15/202222,400 shares $58,912.00 +1.8%0.3%0.5 $2.63 3/31/202222,000 shares $61,600.00 +31.0%0.3%0.5 $2.80 3/15/202216,800 shares $60,648.00 -35.6%0.2%0.5 $3.61 2/28/202226,100 shares $109,620.00 -20.7%0.3%0.7 $4.20 2/15/202232,900 shares $177,660.00 -39.1%0.4%1 $5.40 1/31/202254,000 shares $260,820.00 -27.8%0.6%1.6 $4.83 1/15/202274,800 shares $377,740.00 -21.8%0.7%2.2 $5.05 12/31/202195,700 shares $430,650.00 -2.5%0.9%2.4 $4.50 12/15/202198,100 shares $485,595.00 +4.0%1.0%2.3 $4.95 11/30/202194,300 shares $722,338.00 +38.3%0.9%1.6 $7.66 11/15/202168,200 shares $554,466.00 +32.2%0.7%1 $8.13 10/29/202151,600 shares $452,016.00 +11.7%0.6%0.6 $8.76 10/15/202146,200 shares $311,850.00 -50.1%0.5%0.5 $6.75 9/30/202192,500 shares $771,450.00 +2,102.4%1.0%0.7 $8.34 9/15/20214,200 shares $28,854.00 -67.4%0.1%0 $6.87 8/31/202112,900 shares $114,681.00 -16.2%0.1%0.1 $8.89 8/13/202115,400 shares $158,928.00 No Change0.2%0.1 $10.32 TCRX Short Interest - Frequently Asked Questions What is TScan Therapeutics' current short interest? Short interest is the volume of TScan Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 2,030,000 shares of TCRX short. 4.69% of TScan Therapeutics' shares are currently sold short. Learn More on TScan Therapeutics' current short interest. What is a good short interest ratio for TScan Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCRX shares currently have a short interest ratio of 5.0. Learn More on TScan Therapeutics's short interest ratio. What is a good short interest percentage for TScan Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.69% of TScan Therapeutics' floating shares are currently sold short. Is TScan Therapeutics' short interest increasing or decreasing? TScan Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,030,000 shares, an increase of 6.8% from the previous total of 1,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TScan Therapeutics' float size? TScan Therapeutics currently has issued a total of 56,591,000 shares. Some of TScan Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TScan Therapeutics currently has a public float of 43,270,000 shares. How does TScan Therapeutics' short interest compare to its competitors? 4.69% of TScan Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TScan Therapeutics: Mereo BioPharma Group plc (4.40%), Benitec Biopharma Inc. (1.27%), Aura Biosciences, Inc. (3.18%), Cryoport, Inc. (5.08%), Cartesian Therapeutics, Inc. (24.65%), 2seventy bio, Inc. (5.79%), Aquestive Therapeutics, Inc. (11.93%), Taysha Gene Therapies, Inc. (10.85%), Astria Therapeutics, Inc. (6.16%), Atyr PHARMA INC (9.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short TScan Therapeutics stock? Short selling TCRX is an investing strategy that aims to generate trading profit from TScan Therapeutics as its price is falling. TCRX shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TScan Therapeutics? A short squeeze for TScan Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCRX, which in turn drives the price of the stock up even further. How often is TScan Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCRX, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Mereo BioPharma Group Short Squeeze Benitec Biopharma Short Squeeze Aura Biosciences Short Squeeze Cryoport Short Squeeze Cartesian Therapeutics Short Squeeze 2seventy bio Short Squeeze Aquestive Therapeutics Short Squeeze Taysha Gene Therapies Short Squeeze Astria Therapeutics Short Squeeze Atyr PHARMA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TCRX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TScan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TCRX Stock Free TCRX Stock Alerts